Oncology & Specialty

Specialty and oncology medications.

1,171 NDCs in catalog

Vanflyta (Quizartinib)

26.5 mg/1 · Film-Coated Tablet

NDC 65597-0511-04

1 BOTTLE in 1 CARTON (65597-511-04) / 14 TABLET, FILM COATED in 1 BOTTLE

Available to Source

Vanflyta (Quizartinib)

26.5 mg/1 · Film-Coated Tablet

NDC 65597-0511-28

1 BOTTLE in 1 CARTON (65597-511-28) / 28 TABLET, FILM COATED in 1 BOTTLE

Available to Source

Vanflyta (Quizartinib)

17.7 mg/1 · Film-Coated Tablet

NDC 65597-0504-04

1 BOTTLE in 1 CARTON (65597-504-04) / 14 TABLET, FILM COATED in 1 BOTTLE

Available to Source

Vanflyta (Quizartinib)

17.7 mg/1 · Film-Coated Tablet

NDC 65597-0504-28

1 BOTTLE in 1 CARTON (65597-504-28) / 28 TABLET, FILM COATED in 1 BOTTLE

Available to Source

Stivarga (Regorafenib)

40 mg/1 · Film-Coated Tablet

NDC 50419-0171-04

1 BOTTLE, PLASTIC in 1 CARTON (50419-171-04) / 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC

Available to Source

Stivarga (Regorafenib)

40 mg/1 · Film-Coated Tablet

NDC 50419-0171-03

3 BOTTLE, PLASTIC in 1 BOX (50419-171-03) / 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC

Available to Source

Stivarga (Regorafenib)

40 mg/1 · Film-Coated Tablet

NDC 50419-0171-06

4 BOTTLE, PLASTIC in 1 CARTON (50419-171-06) / 21 TABLET, FILM COATED in 1 BOTTLE, PLASTIC

Available to Source

Stivarga (Regorafenib)

40 mg/1 · Film-Coated Tablet

NDC 50419-0171-00

210 BOTTLE in 1 BOX (50419-171-00) / 28 TABLET, FILM COATED in 1 BOTTLE

Available to Source

Rhapsido (Remibrutinib)

25 mg/1 · Tablet

NDC 00078-1483-92

2 BOTTLE in 1 CARTON (0078-1483-92) / 30 TABLET in 1 BOTTLE

Available to Source

Rhapsido (Remibrutinib)

25 mg/1 · Tablet

NDC 00078-1483-93

30 TABLET in 1 BOTTLE

Available to Source

Rhapsido (Remibrutinib)

25 mg/1 · Tablet

NDC 00078-1483-20

60 TABLET in 1 BOTTLE

Available to Source

Augtyro (Repotrectinib)

40 mg/1 · Capsule

NDC 00003-4040-60

60 CAPSULE in 1 BOTTLE

Available to Source

Augtyro (Repotrectinib)

40 mg/1 · Capsule

NDC 00003-4040-12

120 CAPSULE in 1 BOTTLE

Available to Source

Augtyro (Repotrectinib)

160 mg/1 · Capsule

NDC 00003-4160-14

14 CAPSULE in 1 BOTTLE

Available to Source

Augtyro (Repotrectinib)

160 mg/1 · Capsule

NDC 00003-4160-60

60 CAPSULE in 1 BOTTLE

Available to Source

Kisqali (Ribociclib)

200 mg/1 · Film-Coated Tablet

NDC 00078-0860-01

1 BLISTER PACK in 1 CARTON (0078-0860-01) / 21 TABLET, FILM COATED in 1 BLISTER PACK

Available to Source

Kisqali (Ribociclib)

200 mg/1 · Film-Coated Tablet

NDC 00078-0874-63

3 BLISTER PACK in 1 CARTON (0078-0874-63) / 21 TABLET, FILM COATED in 1 BLISTER PACK

Available to Source

Kisqali (Ribociclib)

200 mg/1 · Film-Coated Tablet

NDC 00078-0867-42

3 BLISTER PACK in 1 CARTON (0078-0867-42) / 14 TABLET, FILM COATED in 1 BLISTER PACK

Available to Source

Litfulo (Ritlecitinib)

50 mg/1 · Capsule

NDC 63539-0334-28

28 CAPSULE in 1 BOTTLE

Available to Source

Litfulo (Ritlecitinib)

50 mg/1 · Capsule

Available to Source

Ritonavir

100 mg/1 · Tablet

NDC 65162-0061-06

60 TABLET in 1 BOTTLE

Available to Source

Ritonavir

100 mg/1 · Tablet

NDC 65162-0061-32

360 TABLET in 1 BOTTLE

Available to Source

Ritonavir

100 mg/1 · Film-Coated Tablet

NDC 68071-3898-03

3 TABLET, FILM COATED in 1 BOTTLE

Available to Source

Ritonavir

100 mg/1 · Film-Coated Tablet

NDC 71335-2610-01

15 TABLET, FILM COATED in 1 BOTTLE

Available to Source